ArticleChinese herbal medicines2023
Production of hispidin polyphenols from medicinal mushroom
Article in Chinese herbal medicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 13 citations in OpenAlex.
- The First Whole Genome Sequence and Methylation Profile ofJournal of fungi (Basel, Switzerland) · 2025Article
- Genome-Wide Transcriptome Analysis Reveals GRF Transcription Factors Involved in Methyl Jasmonate-Induced Flavonoid Biosynthesis inPlants (Basel, Switzerland) · 2025Article
- From Logs to Bags: A Metabolic Blueprint of Sanghuang Cultivation Revealed by UPLC-Q-TOF-MS/MS and Amino Acid Profiling.Molecules (Basel, Switzerland) · 2025Article
- Decoding the Tissue-Specific Profiles of Bioactive Compounds inJournal of fungi (Basel, Switzerland) · 2025Article
- Article
- Isolation and Antioxidant Mechanism of Polyphenols fromAntioxidants (Basel, Switzerland) · 2024Article
- Evaluating the Therapeutic Effect of Hispidin on Prostate Cancer Cells.International journal of molecular sciences · 2024Article
- Antioxidant activity ofHeliyon · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The medicinal mushroom Methods: In this study, the polyunsaturated fatty acids (PUFAs), linoleic acid (LA), linolenic acid (ALA), and methyl jasmonate (MeJa) were employed as the stimulant agents to coordinate the accumulation of biomass and hispidin polyphenols in its submerged cultures Results: The addition of LA and ALA promoted the mycelial accumulation, while the addition of MeJa inhibited the growth of Conclusion: The supplement of PUFAs affects the synthesis and composition of hispidin polyphenols in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.